---
title: "Marksans Pharma Ltd (MARKSANS) — Share Price, Financials & Analysis"
symbol: "MARKSANS"
company: "Marksans Pharma Ltd"
canonical: "https://tapetide.com/stocks/MARKSANS"
isin: "INE750C01026"
nse_symbol: "MARKSANS"
bse_code: "524404"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 14788.54
generated_at: "2026-09-13T18:16:12.135Z"
---

# Marksans Pharma Ltd (MARKSANS)

Canonical page: https://tapetide.com/stocks/MARKSANS

## Company

- **NSE Symbol:** MARKSANS
- **BSE Code:** 524404
- **ISIN:** INE750C01026
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2002-01-21
- **CEO:** Mr. Mark B. Saldanha
- **Employees:** 1840
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** marksanspharma.com

## About

Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products  [1]

## Latest Price

- **Price:** ₹329.4
- **Change:** -1 (-0.3%)
- **Open:** ₹325
- **Day High:** ₹333.75
- **Day Low:** ₹324.2
- **Previous Close:** ₹330.4
- **Volume:** 1631814
- **As Of:** 2026-09-11T10:25:08+00:00

## Key Fundamentals

Observed at 2026-09-11T04:37:30.999189Z.

- **Market Cap:** ₹14788.54 Cr
- **Classification:** Smallcap
- **P/E (reported):** 28.7
- **P/E (TTM):** 28.87
- **EPS (TTM):** ₹11.41
- **EPS (reported):** ₹7.37
- **Book Value:** ₹66.71
- **Price to Book:** 4.95
- **Dividend Yield:** 0.27%
- **ROE:** 13.76%
- **ROCE:** 17.54%
- **Debt to Equity:** 0.11
- **Revenue (yearly):** ₹3033.5 Cr
- **Net Income:** ₹420.1 Cr
- **EBITDA:** ₹683.3 Cr
- **52-Week High:** ₹349.95
- **52-Week Low:** ₹155
- **RSI (14):** 60.83

## Tapetide Score

- **Score:** 64 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Rising
- **Percentile:** 95.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 76.39 | 9% |
| growth | 58.76 | 9% |
| momentum | 93.71 | 12% |
| ownership | 54.8 | 24% |
| quality | 52.09 | 22% |
| valuation | 67.4 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 121.68% | 98.83% | 361.55% |
| ebitda margin growth | 3.38% | 1.17% | -1.4% | 14.83% |
| net income growth | 6.98% | 9.8% | 16% | 12% |
| revenue growth | -2.82% | 12.8% | 17% | 16% |
| roce | 3.52% | -6.05% | -7.54% | 18.77% |
| roe | 6.97% | -10.47% | 14.74% | -9.95% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 531 | 586 | 560 | 591 | 642 | 682 | 708 | 620 | 720 | 754 | 856 | 841 |
| Expenses | 417 | 453 | 450 | 462 | 495 | 543 | 582 | 520 | 576 | 594 | 661 | 628 |
| Operating Profit | 114 | 133 | 110 | 128 | 147 | 139 | 127 | 100 | 144 | 161 | 195 | 213 |
| OPM % | 21 | 23 | 20 | 22 | 23 | 20 | 18 | 16 | 20 | 21 | 23 | 25 |
| Other Income | 19 | 5 | 17 | 15 | 0 | 28 | 15 | 6 | 22 | 20 | 35 | 25 |
| Interest | 2 | 3 | 5 | 3 | 3 | 3 | 3 | 6 | 6 | 6 | 6 | 7 |
| Depreciation | 18 | 22 | 21 | 20 | 20 | 21 | 23 | 23 | 27 | 24 | 24 | 25 |
| Profit before tax | 114 | 113 | 100 | 120 | 125 | 143 | 116 | 77 | 133 | 151 | 200 | 207 |
| Tax % | 26 | 26 | 23 | 26 | 22 | 27 | 22 | 24 | 26 | 25 | 25 | 23 |
| Net Profit | 84 | 83 | 78 | 89 | 98 | 105 | 91 | 58 | 99 | 114 | 149 | 159 |
| EPS in Rs | 1.84 | 1.84 | 1.73 | 1.96 | 2.13 | 2.31 | 2 | 1.29 | 2.17 | 2.5 | 3.27 | 3.47 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 913 | 1000 | 1134 | 1376 | 1491 | 1852 | 2177 | 2623 | 2951 | 3172 |
| Expenses | 834 | 868 | 942 | 1037 | 1232 | 1513 | 1719 | 2090 | 2350 | 2458 |
| Operating Profit | 78 | 132 | 192 | 340 | 259 | 340 | 459 | 533 | 601 | 714 |
| OPM % | 9 | 13 | 17 | 25 | 17 | 18 | 21 | 20 | 20 | 22 |
| Other Income | 8 | 5 | 0 | 7 | 42 | 59 | 50 | 66 | 82 | 102 |
| Interest | 10 | 10 | 9 | 8 | 8 | 9 | 11 | 12 | 24 | 25 |
| Depreciation | 27 | 23 | 27 | 36 | 45 | 52 | 74 | 83 | 99 | 100 |
| Profit before tax | 50 | 104 | 157 | 302 | 248 | 338 | 424 | 504 | 561 | 691 |
| Tax % | 28 | 23 | 23 | 21 | 25 | 21 | 26 | 24 | 25 | — |
| Net Profit | 36 | 80 | 121 | 239 | 187 | 265 | 315 | 383 | 420 | 521 |
| EPS in Rs | 0.8 | 1.87 | 2.95 | 5.76 | 4.51 | 5.88 | 6.92 | 8.4 | 9.22 | 11.41 |
| Dividend Payout % | 6 | 3 | 3 | 4 | 6 | 9 | 9 | 10 | 10 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 41 | 41 | 41 | 41 | 41 | 41 | 45 | 45 | 45 | 45 |
| Reserves | 392 | 430 | 502 | 595 | 846 | 1161 | 1700 | 2020 | 2422 | 2978 |
| Borrowings | 110 | 118 | 100 | 30 | 34 | 111 | 123 | 244 | 322 | 343 |
| Other Liabilities | 209 | 142 | 160 | 236 | 307 | 323 | 322 | 372 | 451 | 489 |
| Total Liabilities | 752 | 731 | 802 | 902 | 1228 | 1636 | 2190 | 2681 | 3240 | 3856 |
| Fixed Assets | 267 | 279 | 270 | 303 | 309 | 428 | 486 | 776 | 982 | 1044 |
| CWIP | 0 | 0 | 0 | 0 | 12 | 3 | 10 | 9 | 27 | 59 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 27 | 1 | 0 |
| Other Assets | 484 | 451 | 533 | 599 | 907 | 1205 | 1694 | 1869 | 2230 | 2753 |
| Total Assets | 752 | 731 | 802 | 902 | 1228 | 1636 | 2190 | 2681 | 3240 | 3856 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 14 | 50 | 27 | 233 | 179 | 99 | 237 | 230 | 207 | 458 |
| Cash from Investing Activity | -21 | -39 | -13 | -60 | -45 | -84 | -259 | -141 | -49 | -249 |
| Cash from Financing Activity | -3 | 3 | -21 | -114 | -15 | 80 | 198 | -69 | -65 | -71 |
| Net Cash Flow | -10 | 15 | -7 | 60 | 118 | 94 | 176 | 21 | 93 | 138 |
| Free Cash Flow | -14 | 11 | 14 | 174 | 133 | 53 | 184 | 22 | 35 | 329 |
| CFO/OP | 31 | 73 | 41 | 134 | 67 | 66 | 88 | 77 | 62 | 99 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 118 | 71 | 64 | 78 | 72 | 97 | 82 | 76 | 75 | 80 |
| Inventory Days | 151 | 152 | 215 | 155 | 248 | 216 | 192 | 217 | 270 | 278 |
| Days Payable | 129 | 54 | 78 | 71 | 103 | 102 | 91 | 94 | 98 | 96 |
| Cash Conversion Cycle | 140 | 169 | 202 | 163 | 217 | 211 | 183 | 199 | 247 | 261 |
| Working Capital Days | 77 | 70 | 97 | 87 | 104 | 121 | 122 | 129 | 142 | 149 |
| ROCE % | 4 | 10 | 18 | 25 | 38 | 23 | 22 | 21 | 20 | 19 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 43.85% | 43.85% | 43.85% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% |
| FIIs | 10.88% | 10.88% | 15.57% | 18.6% | 21.31% | 21.96% | 22.2% | 19.88% | 16.92% | 8.12% | 16.76% | 17.47% |
| DIIs | 3.15% | 3.82% | 5.17% | 3.75% | 4.1% | 4.3% | 4.56% | 5.5% | 5.28% | 5.91% | 6.57% | 6.19% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 32.12% | 30.8% | 30.91% | 29.47% | 26.77% | 26.24% | 25.77% | 26.75% | 29.53% | 28.98% | 28.33% | 28.05% |
| Others | 10% | 10.64% | 4.49% | 4.31% | 3.95% | 3.63% | 3.59% | 4% | 4.4% | 13.11% | 4.45% | 4.42% |
| No. of Shareholders | 207937 | 237377 | 254699 | 235500 | 248845 | 259813 | 257273 | 256221 | 265788 | 255153 | 246279 | 246635 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 5 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 329.64 | Sell |
| EMA (10) | 329.29 | Buy |
| SMA (20) | 327.64 | Buy |
| EMA (20) | 322.22 | Buy |
| SMA (50) | 292.93 | Buy |
| EMA (50) | 298.19 | Buy |
| SMA (100) | 260.77 | Buy |
| EMA (100) | 269.11 | Buy |
| SMA (200) | 218.83 | Buy |
| EMA (200) | 242.21 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 59.98 | Neutral |
| MACD (12,26,9) | 11.11 | Sell |
| Stochastic (14,3,3) | 45.82 | Neutral |
| ADX (14) | 38.84 | Buy |
| Williams %R (14) | -55.77 | Neutral |
| ATR (14) | 12.91 | High Volatility |
| ROC (12) | -0.5 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 41.49 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 2 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 2 analyst ratings, observed at 2026-09-11T04:37:30.994216+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=673613e1-2b50-4c50-8a04-839f8f3c1d56.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c34eb17b-c138-4d8c-bde0-44d3cc4ac68f.pdf) |
| 2026-08-27 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76422d48-8f68-48ef-b4df-4c911bd866b1.pdf) |
| 2026-08-27 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ad68837-7496-4150-90e8-daab72930780.pdf) |
| 2026-08-27 | [Voting Results Of The 34Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54fd2e01-0d09-4455-8916-7831cfa94899.pdf) |
| 2026-08-26 | [Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50326cb2-ddcf-4431-9683-c40483bb996c.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0d3928c-e816-40a4-8987-96c0ead7d573.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 12 August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48fc00a6-e6f5-4add-9e02-67bed9bd554d.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9915c9b6-63e1-4962-8620-51f22749c121.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc5bd833-48bc-437a-b417-f720832d8e1d.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fba06bfd-8b19-4931-9fa2-5b7d65fde69c.pdf) |
| 2026-06-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70dd9fb2-015b-4a0f-9236-e7d3590c653b.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebecc4ff-caba-46d7-bfc8-af5f501d091f.pdf) |
| 2025-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce04a0c-323d-435b-9e1c-36e0c80b2242.pdf) |
| 2025-02-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a9c046-2eec-42a4-af77-ed6caa22efd3.pdf) |
| 2025-02-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de9e78c7-d9a6-47b3-99fb-3024051aaec2.pdf) |
| 2024-11-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25a27757-30ac-4034-ac29-1c4f9596f2c6.pdf) |
| 2024-08-22 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb086858-4995-41a6-adf5-d076c0535e71.pdf) |
| 2024-06-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e63d207-a628-43f3-b3ad-49088a4242ca.pdf) |
| 2024-02-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=759b003c-c3fe-4e50-a2df-cb8d111c7e8b.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a673cc6-f25a-476b-b016-5cfbf99dfa76.pdf) |
| 2026-05-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21f6e46f-981a-4197-8850-300cc0a9bf85.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0af9e3cc-f480-4488-ac3c-c7925b56faaa.pdf) |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9debd3e1-3efd-4d2b-832f-e88e6d24083f.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f0e8f16-4a38-474a-8048-739383fa268e.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d85a0812-8eb9-4f90-afa8-eb2b8693a88f.pdf) |
| 2024-02-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7aeb6f7-8d24-4d02-b4fe-bfa6381eb42e.pdf) |
| 2023-11-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddab8503-2adb-4c89-953d-8500f33817b0.pdf) |
| 2023-08-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39465d25-3902-47b5-8109-60ce8b0d318c.pdf) |
| 2023-05-31 | [Announcement Under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f2c2a18-0891-41b0-b835-cde464a3e869.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Result For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e51ec0f9-194a-450e-aac6-3d7d7fe80332.pdf) |
| 2026-05-26 | [Audited Financial Results For The Quarter And Year Ended 31 March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=293151f2-7191-4b90-b083-6599468557fc.pdf) |
| 2026-02-05 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=886eea3a-1634-4e4d-a3dd-0c495902a4b7.pdf) |
| 2025-11-13 | [Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b17921f2-848b-43b5-b5dc-6ce569651876.pdf) |
| 2025-08-12 | [Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6715072-2e02-4ab4-bc98-82772576b9eb.pdf) |
| 2025-05-19 | [Audited Results For The Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba3fcba1-d8ae-4f48-ae08-cefeb491cdc0.pdf) |
| 2025-02-11 | [Financial Results For Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac54d7f2-a381-4c74-89a4-fb173e8de227.pdf) |
| 2024-11-12 | [Financial Results For Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95a8d751-081a-4ca9-a055-b69d10aecddb.pdf) |
| 2024-08-13 | [Financial Result For Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fb74909-d5a1-4434-8554-54d08cbac240.pdf) |
| 2024-05-30 | [Audited Financial Results For FY24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63997228-0914-401a-a72e-24d4c7728857.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4d58726-b6a1-42c7-b3e2-906318cb06eb.pdf) |
| 2026-05-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be80033c-c39d-438c-a689-810e7f18d1d4.pdf) |
| 2026-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06ee0731-fe61-4466-9013-15e76d05ed7b.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=561963c2-f7bd-403c-8ef9-fe5811634512.pdf) |
| 2025-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7449f75b-f499-4f5c-a133-db74f1549d81.pdf) |
| 2025-05-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3ccd2d1-b84e-4cba-82bd-0082038c7d29.pdf) |
| 2025-02-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c3e40b8-5740-4fae-be66-d0d040b09b93.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=421eca1a-2738-45e2-b849-1fa434718354.pdf) |
| 2024-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52a65efa-c5b2-4cea-b4c8-af52a2d2dcb7.pdf) |
| 2024-05-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f11415cc-06c3-4ce6-a99f-d7cd31980047.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9eeec949-4a87-4c3e-9c42-2eacdadff9d1.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/25a27757-30ac-4034-ac29-1c4f9596f2c6.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c84979e4-afdd-4054-9077-8f9413709883.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/96366b09-0e35-4d56-910f-5f957c45d023.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b438d166-1877-44a3-920c-4ff0316d2195.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75af85bd-fd7b-402d-aad2-b96367eb9bd7.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75af85bd-fd7b-402d-aad2-b96367eb9bd7.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be80033c-c39d-438c-a689-810e7f18d1d4.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/be80033c-c39d-438c-a689-810e7f18d1d4.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab69125c-8c67-406d-9ac1-8238d693da3f.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026 | [Compliances-Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations, 2018 9 Apr - Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/575b8787-e59c-4acd-b6e3-e2f7e8ab786a.pdf) |
| 6 Feb - Newspaper Publication of Un-Audited Financial Results for the Quarter and Nine months ended 31 December, 2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb - Newspaper Publication of Un-Audited Financial Results for the Quarter and Nine months ended 31 December, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/273f60d8-833f-4e04-a2b3-2bcb4e6d0651.pdf) |
| 6 Feb - Audio recording of Q3 & 9M FY26 investor/analyst conference call uploaded on 06 Feb 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 6 Feb - Audio recording of Q3 & 9M FY26 investor/analyst conference call uploaded on 06 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0af9e3cc-f480-4488-ac3c-c7925b56faaa.pdf) |
| 12 Mar - Newspaper publication regarding opening of special window for re-lodgement of the transfer request for physical shares | [Announcement under Regulation 30 (LODR)-Newspaper Publication 12 Mar - Newspaper publication regarding opening of special window for re-lodgement of the transfer request for physical shares](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02f89b87-14f4-40a8-b24a-6927691f3849.pdf) |
| 12 Feb - Marksans Pharma Limited submits transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 12 Feb - Marksans Pharma Limited submits transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ebecc4ff-caba-46d7-bfc8-af5f501d091f.pdf) |
| 11 Mar - Special window Feb 5, 2026–Feb 4, 2027 for re-lodgement of pre-April 1, 2019 physical share transfers. | [Intimation Regarding Opening Of Special Window For Re-Lodgment Of Transfer Requests Of Physical Shares 11 Mar - Special window Feb 5, 2026–Feb 4, 2027 for re-lodgement of pre-April 1, 2019 physical share transfers.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/702e4657-395a-4a19-962f-4cc3f794ee97.pdf) |
| 10 Mar - Officials to participate in Investec India Promoter & Founder Conference on 11 March 2026, 11:00 IST, Trident BKC. | [Investec India Promoter & Founder Conference 2026 10 Mar - Officials to participate in Investec India Promoter & Founder Conference on 11 March 2026, 11:00 IST, Trident BKC.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/56c5fcd3-8eba-433c-b410-c313acf9a788.pdf) |
| 1 Apr - USFDA final approval for Benzonatate Capsules USP 100 mg and 200 mg (ANDA) on April 1, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 1 Apr - USFDA final approval for Benzonatate Capsules USP 100 mg and 200 mg (ANDA) on April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bbe3940-156a-4234-bb43-72a3adf7268a.pdf) |
| — | [Closure of Trading Window 26 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/051bdb14-e9f4-415e-af2f-40e6f26f72cf.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08765805-8bf0-4135-9363-de1d0660992a.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1943f867-06b1-4f09-82b4-cd49f7aa2d97.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7a3122d-b239-4c5c-bcc3-291bab56d370.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f8a7b27d-8c98-4788-8bcf-091f94986d4f.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524404/74127524404.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524404/70224524404.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524404/65570524404.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:16:12.135Z.